JPMorgan Double Downgrades Absci Corp. (ABSI) to Underweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to JPMorgan Double Downgrades Absci Corp. (ABSI) to Underweight
August 11, 2022 8:00 AM EDT
Exceeded annual Active Program guidance with ten programs signed year-to-date
Executed strategic reorganization to extend cash runway into late-2025
VANCOUVER, Wash. and NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended June 30, 2022.
"As we pass the halfway point of 2022, our team continues to make excellent progress toward... More
August 11, 2022 8:00 AM EDT
Exceeded annual Active Program guidance with ten programs signed year-to-date
Executed strategic reorganization to extend cash runway into late-2025
VANCOUVER, Wash. and NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended June 30, 2022.
"As we pass the halfway point of 2022, our team continues to make excellent progress... More
